Coronavirus disease 2019 (COVID‐19) is spreading worldwide. All aspects of pregnancy management from conception to delivery to puerperium as risks facing newborns are herein, reviewed. Maternal home management and prenatal care management protection, delivery timing or mode selection, delivery process management, and subsequent puerperal protection are crucial. In this Review, the features and treatment strategies, especially emphasizing the safety of antiviral drugs for pregnant women, the wearing of face masks, and practicing of personal hygiene (e.g., handwashing, disinfection, home cleaning, and ventilation) are reviewed as essential protective measures. It is recommended to provide online consultation, telemedicine, and remote fetal heart rate monitoring and set the flow point for prenatal examination to encourage prenatal examination at home or postponing examinations (except nuchal translucency at 11‐13+6 weeks, Oscar Test at 16 weeks, and fetal ultrasound at 20–24 weeks). It is shown that the precise formulation of follow‐up strategies for pregnant women with COVID‐19 is necessary.
The 2019 novel coronavirus disease is spreading all over the world. Pregnant women and infants require particular concern, owing to the special immune conditions. A case of a pregnant woman who was exposed to SARS‐CoV‐2 at 34+1 weeks gestation and chose to continue pregnancy is reported. Without obvious symptoms or signs, the woman did not receive any treatment before delivery, and gave birth at 37+5 weeks to a neonate with positive immunoglobulin G for SARS‐CoV‐2 and negative nucleic acid tests. The mother was given anti‐infection, oxytocin, and fluid rehydration treatment after delivery. Both mother and infant recovered well after a three‐month follow‐up. Continued expectation to deliver at term instead of preterm can decrease the potential risk of severe perinatal and infant complications and is beneficial to the development of the neonate. More studies are required to confirm the presence of vertical transmission.
Purpose: The aim of this cross-sectional study was to assess the association between sleep status and myopia in children and adolescents.Methods: Stratified cluster sampling a total of 30,188 schoolchildren from 14 schools located in 6 streets (Xinxiang, Songgang, Shiyan, Fuyong, Shajing and Xinan) of Baoan District in Shenzhen, China. The demographic characteristics of schoolchildren, information of self-reported myopia and their sleep status in the last 1 month were collected through using a standardized questionnaire. χ2-test was used to compare differences in myopia rates among children and adolescents in different sleep status. Logistic regression models were used to analyze the association of sleep status with myopia in children and adolescents.Results: The self-reported myopia rates was 49.8% among children and adolescents in Shenzhen. In primary, junior high and senior high students, the myopia rates were 25.6%, 62.4%, and 75.7%, respectively. After controlling for confounders, the results of multiple logistic analysis showed that night sleep duration < 7h/d (OR = 2.02, 95%CI: 1.87-2.19), falling asleep at a fixed time (no) (OR = 1.14, 95%CI: 1.08-1.20), getting up at a fixed time in the morning (no) (OR = 1.28, 95%CI: 1.19-1.37), putting off sleeping on weekends ≥ 2 h/d (OR = 1.28, 95%CI: 1.17-1.41) and Putting off getting up on weekends ≥ 2 h/d were risk factors (OR = 1.23, 95%CI: 1.13-1.34). After stratified by grade, social jet lag was not associated with myopia among senior high students.Conclusion: Insufficient sleep duration was positively associated with self-reported myopia, irregular patterns of sleep and social jet lag increased the risk of myopia among schoolchildren. Myopia prevention and control among children and adolescents should not only ensure adequate sleep, but also develop a habit of regular sleep.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.